Vivozon Pharmaceutical Co., Ltd. (KOSDAQ: 082800)

Vivozon Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct 11, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	200,287	144,635	149,085	186,048	296,774	249,937
Market Cap Growth	-14.78%	-2.99%	-19.87%	-37.31%	18.74%	146.51%
Enterprise Value	229,314	174,909	188,576	192,882	339,521	372,366
Last Close Price	4215.00	3000.00	3185.00	5475.00	10550.00	10475.00
PE Ratio	-	-42.64	-3.47	-2.57	-6.31	-7.86
PS Ratio	2.45	2.03	2.89	3.23	6.81	5.56
PB Ratio	1.93	1.39	1.44	2.15	2.66	2.29
P/FCF Ratio	-51.92	-94.42	-15.19	-6.74	79.02	-60.87
P/OCF Ratio	31.73	48.35	-44.86	-10.63	64.17	-64.19
EV/Sales Ratio	2.81	2.45	3.66	3.35	7.79	8.28
EV/EBITDA Ratio	29.33	22.04	-30.60	-13.72	-57.94	-554.03
EV/EBIT Ratio	51.92	37.14	-19.23	-9.83	-42.23	-133.52
EV/FCF Ratio	-81.40	-114.19	-19.21	-6.99	90.41	-90.69
Debt / Equity Ratio	0.38	0.40	0.58	0.97	0.97	0.38
Debt / EBITDA Ratio	5.03	5.24	-	-	-	-
Debt / FCF Ratio	-13.96	-27.17	-6.15	-3.05	28.87	-10.17
Asset Turnover	0.46	0.40	0.27	0.26	0.21	0.34
Inventory Turnover	2.70	3.31	2.21	2.62	4.67	7.96
Quick Ratio	0.16	0.48	0.45	0.87	0.91	1.37
Current Ratio	0.64	0.70	0.60	1.08	1.06	1.46
Return on Equity (ROE)	-2.56%	-2.13%	-28.26%	-71.70%	-39.98%	-25.52%
Return on Assets (ROA)	1.56%	1.63%	-3.21%	-5.54%	-2.43%	-1.31%
Return on Capital (ROIC)	1.86%	1.90%	-3.67%	-6.28%	-2.71%	-1.44%
Earnings Yield	-1.35%	-2.32%	-26.77%	-37.33%	-14.74%	-11.20%
FCF Yield	-1.41%	-1.06%	-6.58%	-14.84%	1.27%	-1.64%
Buyback Yield / Dilution	-0.13%	-9.69%	-33.41%	-24.52%	-24.63%	-65.66%
Total Shareholder Return	-0.13%	-9.69%	-33.41%	-24.52%	-24.63%	-65.66%

Source: S&P Capital IQ. Standard template. Financial Sources.